Logotype for Quantum Computing Inc

Quantum Computing (QUBT) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Quantum Computing Inc

Q3 2025 earnings summary

8 Jul, 2026

Executive summary

  • Achieved 280% year-over-year revenue growth in Q3 2025, driven by increased R&D services, custom hardware contracts, and the launch of cloud-based quantum computing services, including a major sale to a top 5 U.S. bank.

  • Ended Q3 2025 with a strengthened balance sheet and over $1.5 billion in liquidity after raising $1.25 billion in private placements and $756.5 million in equity offerings.

  • Net income for Q3 2025 was $2.4 million ($0.01/share), a turnaround from a net loss of $5.7 million in Q3 2024, primarily due to non-operating gains including a $9.2 million derivative liability gain and $3.5 million interest income.

  • Advanced commercial traction in quantum AI, cybersecurity, and government partnerships, notably with NASA.

  • Expanded engineering and operations teams to support growth and execution.

Financial highlights

  • Q3 2025 revenue was $384,000 (33% gross margin), up from $101,000 (9% gross margin) in Q3 2024, driven by increased R&D and hardware contracts.

  • Operating expenses rose to $10.5 million from $5.4 million year-over-year, reflecting increased investment in R&D, sales, and manufacturing.

  • For the nine months ended September 30, 2025, net loss was $17.1 million ($0.12/share), slightly improved from $17.3 million ($0.19/share) in the prior year.

  • Ended Q3 with $352.4 million in cash, $460.6 million in investments, $20.3 million in liabilities, and $877.9 million in stockholders' equity.

  • Working capital at Q3 2025: $559.2 million (Q4 2024: $74.6 million).

Outlook and guidance

  • Roadmap prioritizes scaling small-batch production, refining processes, and preparing for industrial-scale output by decade's end, with Fab 2 development planned over the next three years.

  • Management expects continued investment in R&D and go-to-market programs, anticipating ongoing operating losses until substantial product revenue is achieved.

  • No additional financing expected; share count projected at 224 million for Q4 2025.

  • M&A remains a strategic focus to accelerate commercialization and expand product lines.

  • Current liquidity is expected to cover operational needs for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more